The Best Research Peptides for Metabolic Studies in 2026
Metabolic research is the most active area in the peptide field right now, and the list of compounds under study keeps growing. This overview summarizes the metabolic research peptides drawing the most attention in 2026 and how their mechanisms differ.
The incretin agonists
The headline category is the incretin receptor agonists. Semaglutide (single GLP-1), tirzepatide (dual GIP/GLP-1), and retatrutide (triple GIP/GLP-1/glucagon) form a clear progression. Our agonist guide breaks down the differences, and the retatrutide explainer covers the most-watched of the group.
Amylin analogs
Cagrilintide is the leading long-acting amylin analog and works through an appetite pathway distinct from GLP-1 — which is why it has been studied in combination with semaglutide. See our cagrilintide overview for the CagriSema research.
Mitochondrial and cellular-energy peptides
MOTS-c is a mitochondrial-derived peptide studied for its role in metabolic regulation and energy homeostasis, representing a different angle from the incretin compounds.
Small-molecule metabolic compounds
5-Amino-1MQ is a small molecule studied as an NNMT inhibitor in metabolic research — a mechanism unrelated to receptor agonism. Our 5-Amino-1MQ article goes deeper.
Choosing for a research program
The right compound depends entirely on the mechanism a study is designed to investigate — incretin signaling, amylin pathways, mitochondrial function, or enzyme inhibition. All are supplied as lyophilized powder and reconstituted with bacteriostatic water; see our reconstitution guide.
Research use only. This article is educational and is not medical advice. The compounds discussed are not approved for human or veterinary use, consumption, or therapeutic application.